Clinical Trials › NCT05395624
RecruitingPhase 1
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
Sponsored by Ashvattha Therapeutics, Inc.
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 65
Target enrollment
2
U.S. states
Feb 2023
Start date
May 2026
Expected completion
Interventions / Treatments
18F-OP-801
Conditions studied
Multiple Sclerosis (MS)
Where this trial is running (3 sites)
California2 sites
San Francisco · Stanford
Florida1 site
Jacksonville
Participating MS centers on MS Buddy (3)
Mayo Clinic Florida MS Program
Jacksonville, FL
Jacksonville, FL
Stanford MS & Neuroimmunology Clinic
Palo Alto, CA
Palo Alto, CA
UCSF Multiple Sclerosis Center
San Francisco, CA
San Francisco, CA
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.